Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2000
07/05/2000EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
07/05/2000EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
07/05/2000EP0565621B1 Method of making camptothecin and camptothecin analogs
07/05/2000CN1259123A Method for the production of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyride-6-one-monosodium salt and its tautomers
07/05/2000CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use
07/05/2000CN1259118A Organic compound
07/05/2000CN1259017A Non-spherical and non-platelet pyrithione salts
07/05/2000CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component
07/05/2000CN1258672A Amino-compound
07/04/2000US6084120 β-Alkoxyacrylates against malaria
07/04/2000US6084105 Cyclization in the presence of a base a 2-arylhydrazino-succinonitrile compound to produce a 5-amino-1-aryl-3-cyano-pyrazole pesticide intermediate
07/04/2000US6084101 Raw materials for dyes, pigments and photosensitive compounds; 2-hydroxy-3(6)-heterocyclylamido-3,(6)-metoxycarbonylnaphthalenes
07/04/2000US6083991 Anti-arrhythmic composition and methods of treatment
07/04/2000US6083987 Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
07/04/2000US6083964 Antiepileptic pharmaceutical compositions with no neurotoxicity
07/04/2000US6083960 Constrained somatostatin agonists and antagonists
07/04/2000US6083955 Having a high affinity for drugs, especially endoserine receptors
07/04/2000US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists
07/04/2000US6083938 Pyridinylbisphosphonates for use as a therapeutical agent
07/04/2000US6083903 Boronic ester and acid compounds, synthesis and uses
07/04/2000CA1341047C 4-(n-benzyl-n-methylamino) pyridine acid salts and use in preparation of polymer-supported catalysts
07/04/2000CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents
06/2000
06/29/2000WO2000037446A1 Method for producing heteroaromatic aldehydes
06/29/2000WO2000037438A1 Novel thio-aminotetralin compounds useful in pain management
06/29/2000WO2000037434A1 Amide derivatives
06/29/2000WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
06/29/2000WO2000037428A1 Process for the preparation of aromatic carboxylic acid amides
06/29/2000WO2000037422A2 Ion channel modulating agents
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000012472A3 Process for preparing certain phenyl urea compounds
06/29/2000WO2000002887A3 Ligands for metals and metal-catalyzed processes
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000DE19918021C1 Preparation of chlorinated pyridine sulfonic acid chloride derivatives from hydroxypyridine sulfonic acids and phosphorus trichloride/chlorine gas; useful as intermediates for drugs, e.g. torasemide
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/28/2000EP1013647A2 Process for the preparation of N-(amino-4,6-dihalogenopyrimidin)-formamides
06/28/2000EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
06/28/2000EP1013636A1 Preparation of allylic aromatic compounds
06/28/2000EP1012892A1 Electroluminescent device
06/28/2000EP1012144A1 Method for producing (hetero)aromatic hydroxylamines
06/28/2000EP1012142A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
06/28/2000EP1012141A1 Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same
06/28/2000CN1258301A Antiviral protease inhibitors
06/28/2000CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them
06/28/2000CN1258280A Cyanoamidines as cell proliferation inhibitors
06/28/2000CN1258279A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258278A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258277A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1258276A Cyanoguanidines as cell proliferation inhibitors
06/28/2000CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them
06/28/2000CN1053899C Acylguanidine, its preparation process and use, and pharmaceutical composition contg. same
06/28/2000CN1053895C Substd. sulfonic acid amide, preparation process and pharmaceutical composition of same
06/28/2000CN1053894C Process for preparing 4,4'-bipyridyl
06/27/2000US6080867 Imidation and cyclization to form a chemical intermediate for making highly potent, environmentally benign, imidazoline herbicidal agents
06/27/2000US6080866 A chemical intermediates for endothelin receptor antagonists
06/27/2000US6080839 Labeling reactants and their use
06/27/2000US6080790 Selective and potent inhibitors of phosphodiesterase iv and are useful for the prophylaxis and treatment of inflammatory diseases and the alleviation of conditions associated with central nervous malfunction
06/27/2000US6080784 A phorbol derivative used as antiinflammatory agent
06/27/2000US6080773 Benzylamine derivatives which are useful in treating psychiatric disorders
06/27/2000US6080768 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
06/27/2000CA2188427C Neurotransmitter release enhancers
06/27/2000CA2180000C Amino-acid amide derivatives, method for producing the same, and agricultural or horticultural fungicides
06/22/2000WO2000036054A1 Ferroelectric active matrix displays with wide operating temperature range
06/22/2000WO2000035882A1 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
06/22/2000WO2000035867A1 Novel ligands of nuclear receptor
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035436A2 Treatment of arthritis with mek inhibitors
06/22/2000WO2000035435A1 Use of a mek inhibitor for preventing transplant rejection
06/22/2000WO2000035430A2 Homer a new target of treating psychiatric disorders
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355299A1 Novel ligands of nuclear receptor
06/22/2000CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000CA2354323A1 Homer a new target of treating psychiatric disorders
06/22/2000CA2353151A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and their use as medicaments
06/22/2000CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000CA2346684A1 Use of a mek inhibitor for preventing transplant rejection
06/22/2000CA2346448A1 Treatment of arthritis with mek inhibitors
06/21/2000EP1010692A1 Liquid-crystal compounds having large value of permittivity anisotropy, liquid-crystal composition containing the same, and liquid-crystal display element made using the liquid-crystal composition
06/21/2000EP1010691A2 Hydrazide derivatives, process for their preparation and pharmaceutical compositions containing them
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009736A1 Malonic acid based matrix metalloproteinase inhibitors
06/21/2000EP1009729A1 Halogenated acrylates and polymers derived therefrom
06/21/2000EP1009402A4 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
06/21/2000EP1009402A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
06/21/2000DE19858029A1 New substituted (hetero)aryl-alkanes, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates
06/21/2000CN1257484A Synthesis of intermediates useful in preparing tricyclic compounds
06/21/2000CN1257481A Novel pyridine derivatives and pharmaceutical compositions containing them
06/21/2000CN1257473A New polymerisable liquid crystalline compounds
06/21/2000CN1053658C Aminostilbazole derivative and medicine
06/21/2000CN1053657C Didepside phthaleins based internal parasite compositions, novel didepside phthaleins and preparation process thereof
06/20/2000US6077957 Process for the preparation of nicotinic acid
06/20/2000US6077954 Substituted heterocyclic compounds
06/20/2000US6077856 Hemoregulatory compounds
06/20/2000US6077855 Hemoregulatory compounds
06/20/2000US6077854 Tri-substituted phenyl derivatives and processes for their preparation